Bb Biotech as of March 31, 2017
Portfolio Holdings for Bb Biotech
Bb Biotech holds 30 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 15.3 | $467M | 3.5M | 133.67 | |
Celgene Corporation | 13.6 | $416M | 3.3M | 124.43 | |
Ionis Pharmaceuticals (IONS) | 9.8 | $300M | 7.5M | 40.20 | |
Gilead Sciences (GILD) | 6.2 | $189M | 2.8M | 67.92 | |
Radius Health | 5.7 | $176M | 4.5M | 38.65 | |
Agios Pharmaceuticals (AGIO) | 5.4 | $166M | 2.8M | 58.40 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $159M | 1.5M | 109.35 | |
Alexion Pharmaceuticals | 4.9 | $149M | 1.2M | 121.24 | |
Neurocrine Biosciences (NBIX) | 4.5 | $139M | 3.2M | 43.30 | |
Tesaro | 4.2 | $127M | 825k | 153.87 | |
Halozyme Therapeutics (HALO) | 3.3 | $100M | 7.7M | 12.96 | |
Regeneron Pharmaceuticals (REGN) | 3.1 | $95M | 245k | 387.51 | |
Sage Therapeutics (SAGE) | 2.3 | $69M | 972k | 71.07 | |
Alnylam Pharmaceuticals (ALNY) | 2.1 | $64M | 1.2M | 51.25 | |
Kite Pharma | 1.9 | $58M | 740k | 78.49 | |
Esperion Therapeutics (ESPR) | 1.6 | $50M | 1.4M | 35.31 | |
Juno Therapeutics | 1.6 | $49M | 2.2M | 22.19 | |
Macrogenics (MGNX) | 1.4 | $42M | 2.3M | 18.60 | |
Myovant Sciences | 1.3 | $39M | 3.3M | 11.74 | |
Alder Biopharmaceuticals | 1.1 | $35M | 1.7M | 20.80 | |
Intra Cellular Therapies (ITCI) | 1.0 | $31M | 1.9M | 16.25 | |
Intercept Pharmaceuticals In | 0.9 | $29M | 256k | 113.10 | |
Five Prime Therapeutics | 0.9 | $26M | 728k | 36.15 | |
Avexis | 0.8 | $25M | 333k | 76.03 | |
Prothena (PRTA) | 0.6 | $20M | 350k | 55.79 | |
Novavax | 0.3 | $11M | 8.3M | 1.28 | |
Puma Biotechnology (PBYI) | 0.3 | $9.1M | 246k | 37.20 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $8.1M | 1.0M | 7.80 | |
Ptc Therapeutics I (PTCT) | 0.2 | $6.7M | 683k | 9.84 | |
Achillion Pharmaceuticals | 0.2 | $5.4M | 1.3M | 4.21 |